150 related articles for article (PubMed ID: 30080722)
1. Circulating Free Methylated Tumor DNA Markers for Sensitive Assessment of Tumor Burden and Early Response Monitoring in Patients Receiving Systemic Chemotherapy for Colorectal Cancer Liver Metastasis.
Bhangu JS; Beer A; Mittlböck M; Tamandl D; Pulverer W; Schönthaler S; Taghizadeh H; Stremitzer S; Kaczirek K; Gruenberger T; Gnant M; Bergmann M; Mannhalter C; Weinhäusel A; Oehler R; Bachleitner-Hofmann T
Ann Surg; 2018 Nov; 268(5):894-902. PubMed ID: 30080722
[TBL] [Abstract][Full Text] [Related]
2. Prognostic influence of hepatic margin after resection of colorectal liver metastasis: role of modern preoperative chemotherapy.
Makowiec F; Bronsert P; Klock A; Hopt UT; Neeff HP
Int J Colorectal Dis; 2018 Jan; 33(1):71-78. PubMed ID: 29098384
[TBL] [Abstract][Full Text] [Related]
3. Postoperative serum methylation levels of TAC1 and SEPT9 are independent predictors of recurrence and survival of patients with colorectal cancer.
Tham C; Chew M; Soong R; Lim J; Ang M; Tang C; Zhao Y; Ong SY; Liu Y
Cancer; 2014 Oct; 120(20):3131-41. PubMed ID: 24925595
[TBL] [Abstract][Full Text] [Related]
4. Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas.
Zhang X; Song YF; Lu HN; Wang DP; Zhang XS; Huang SL; Sun BL; Huang ZG
World J Gastroenterol; 2015 Mar; 21(9):2629-37. PubMed ID: 25759530
[TBL] [Abstract][Full Text] [Related]
5. CEA change after neoadjuvant chemotherapy including bevacizumab and clinical outcome in patients undergoing liver resection for colorectal liver metastases.
Stremitzer S; Stift J; Graf A; Singh J; Starlinger P; Gruenberger B; Tamandl D; Gruenberger T
Ann Surg Oncol; 2015 Apr; 22(4):1315-23. PubMed ID: 25323471
[TBL] [Abstract][Full Text] [Related]
6. Circulating cell-free DNA in plasma of colorectal cancer patients - A potential biomarker for tumor burden.
Bhangu JS; Taghizadeh H; Braunschmid T; Bachleitner-Hofmann T; Mannhalter C
Surg Oncol; 2017 Dec; 26(4):395-401. PubMed ID: 29113658
[TBL] [Abstract][Full Text] [Related]
7. Improved tumour marker sensitivity in detecting colorectal liver metastases by combined type IV collagen and CEA measurement.
Nyström H; Tavelin B; Björklund M; Naredi P; Sund M
Tumour Biol; 2015 Dec; 36(12):9839-47. PubMed ID: 26162539
[TBL] [Abstract][Full Text] [Related]
8. Potential of quantitative SEPT9 and SHOX2 methylation in plasmatic circulating cell-free DNA as auxiliary staging parameter in colorectal cancer: a prospective observational cohort study.
Bergheim J; Semaan A; Gevensleben H; Groening S; Knoblich A; Dietrich J; Weber J; Kalff JC; Bootz F; Kristiansen G; Dietrich D
Br J Cancer; 2018 May; 118(9):1217-1228. PubMed ID: 29610456
[TBL] [Abstract][Full Text] [Related]
9. Cell-Free Circulating Methylated SEPT9 for Noninvasive Diagnosis and Monitoring of Colorectal Cancer.
Fu B; Yan P; Zhang S; Lu Y; Pan L; Tang W; Chen S; Chen S; Zhang A; Liu W
Dis Markers; 2018; 2018():6437104. PubMed ID: 29849824
[TBL] [Abstract][Full Text] [Related]
10. Plasma Dynamics of RAS/RAF Mutations in Patients With Metastatic Colorectal Cancer Receiving Chemotherapy and Anti-EGFR Treatment.
Thomsen CB; Andersen RF; Lindebjerg J; Hansen TF; Jensen LH; Jakobsen A
Clin Colorectal Cancer; 2019 Mar; 18(1):28-33.e3. PubMed ID: 30459076
[TBL] [Abstract][Full Text] [Related]
11. Methylated free-circulating HPP1 DNA is an early response marker in patients with metastatic colorectal cancer.
Herbst A; Vdovin N; Gacesa S; Ofner A; Philipp A; Nagel D; Holdt LM; Op den Winkel M; Heinemann V; Stieber P; Graeven U; Reinacher-Schick A; Arnold D; Ricard I; Mansmann U; Hegewisch-Becker S; Kolligs FT
Int J Cancer; 2017 May; 140(9):2134-2144. PubMed ID: 28124380
[TBL] [Abstract][Full Text] [Related]
12. Circadian Rhythm of Methylated Septin 9, Cell-Free DNA Amount and Tumor Markers in Colorectal Cancer Patients.
Tóth K; Patai ÁV; Kalmár A; Barták BK; Nagy ZB; Galamb O; Wichmann B; Tulassay Z; Molnár B
Pathol Oncol Res; 2017 Jul; 23(3):699-706. PubMed ID: 28035516
[TBL] [Abstract][Full Text] [Related]
13. Host MICA Polymorphism as a Potential Predictive Marker in Response to Chemotherapy for Colorectal Liver Metastases.
Nishioka Y; Shindoh J; Inagaki Y; Gonoi W; Mitsui J; Abe H; Yoshioka R; Yoshida S; Fukayama M; Tsuji S; Hashimoto M; Hasegawa K; Kokudo N
Dig Dis; 2018; 36(6):437-445. PubMed ID: 29969766
[TBL] [Abstract][Full Text] [Related]
14. Type IV collagen as a tumour marker for colorectal liver metastases.
Nyström H; Naredi P; Hafström L; Sund M
Eur J Surg Oncol; 2011 Jul; 37(7):611-7. PubMed ID: 21620632
[TBL] [Abstract][Full Text] [Related]
15. Roles of Methylated DNA Biomarkers in Patients with Colorectal Cancer.
Ma Z; Williams M; Cheng YY; Leung WK
Dis Markers; 2019; 2019():2673543. PubMed ID: 30944663
[TBL] [Abstract][Full Text] [Related]
16. Epigenome-wide discovery and evaluation of leukocyte DNA methylation markers for the detection of colorectal cancer in a screening setting.
Heiss JA; Brenner H
Clin Epigenetics; 2017; 9():24. PubMed ID: 28270869
[TBL] [Abstract][Full Text] [Related]
17. Recurrence risk assessment for stage III colorectal cancer based on five methylation biomarkers in plasma cell-free DNA.
Wang W; Zhu X; Zhang X; Lei C; Zeng Z; Lan X; Cui W; Wang F; Xu S; Zhou J; Wu X; Deng H; Li X; Fan J; Ding Y; Huang Z; Liang L
J Pathol; 2023 Apr; 259(4):376-387. PubMed ID: 36573552
[TBL] [Abstract][Full Text] [Related]
18. Liver resection for gastric cancer metastases.
Viganò L; Vellone M; Ferrero A; Giuliante F; Nuzzo G; Capussotti L
Hepatogastroenterology; 2013 May; 60(123):557-62. PubMed ID: 23635434
[TBL] [Abstract][Full Text] [Related]
19. Concordance of Carcinoembryonic Antigen Ratio and Response Evaluation Criteria in Solid Tumors as Prognostic Surrogate Indicators of Metastatic Colorectal Cancer Patients Treated with Chemotherapy.
Huang SC; Lin JK; Lin TC; Chen WS; Yang SH; Wang HS; Lan YT; Lin CC; Jiang JK; Chang SC
Ann Surg Oncol; 2015 Jul; 22(7):2262-8. PubMed ID: 25586242
[TBL] [Abstract][Full Text] [Related]
20. Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases.
Gallagher DJ; Zheng J; Capanu M; Haviland D; Paty P; Dematteo RP; D'Angelica M; Fong Y; Jarnagin WR; Allen PJ; Kemeny N
Ann Surg Oncol; 2009 Jul; 16(7):1844-51. PubMed ID: 19224284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
